Reply to: "COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated"

J Am Acad Dermatol. 2022 Jul;87(1):e47-e48. doi: 10.1016/j.jaad.2022.03.042. Epub 2022 Mar 29.

¹ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
³ Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Boston, Massachusetts.
⁴ Laboratory of Computer Science, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
⁵ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ysemenov@mgh.harvard.edu.

No abstract available

Publication types